Some allergic reactions in Britain raised concerns, which led Dr. Aleena Banerji, head of the allergy and clinical immunology unit at Massachusetts General Hospital, and her colleagues to review all that’s known about allergic reactions to vaccines.
They offer some advice in a new report, published Dec. 31 in the Journal of Allergy and Clinical Immunology: In Practice, so that people with different allergy histories can safely receive their first COVID-19 vaccine.
They have also developed steps on safely receiving the second dose in those who had a reaction to the first dose of COVID-19 vaccine.
“As allergists, we want to encourage vaccination by reassuring the public that both FDA-approved COVID-19 vaccines are safe,” Banerji said in a hospital news release. “Our guidelines are built upon the recommendations of U.S. regulatory agencies and provide clear steps to the medical community on how to safely administer both doses of the vaccine in individuals with allergic histories.”
Allergic reactions to vaccines are rare, occurring in about 1.3 per 1 million people. The Pfizer-BioNTech and Moderna COVID-19 vaccines will have a similarly low rate, the researchers said.
Also, vaccine clinics will monitor all patients for 15 to 30 minutes and can manage any allergic reactions that occur, they noted.
People with a history of severe allergy (anaphylaxis) to a drug or vaccine should speak with their allergists before being vaccinated. Those with severe allergies to foods, oral drugs, latex or venom can be safely vaccinated, Banerji and her group said.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022